Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years

Por um escritor misterioso

Descrição

Goods and Bads of the Endocannabinoid System as a Therapeutic Target:  Lessons Learned after 30 Years
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Goods and Bads of the Endocannabinoid System as a Therapeutic Target:  Lessons Learned after 30 Years
Adverse Health Effects of Marijuana Use
Goods and Bads of the Endocannabinoid System as a Therapeutic Target:  Lessons Learned after 30 Years
The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma - ScienceDirect
Goods and Bads of the Endocannabinoid System as a Therapeutic Target:  Lessons Learned after 30 Years
Visualizing lipid receptor localization and activation. (A) CB1 and CB2
Goods and Bads of the Endocannabinoid System as a Therapeutic Target:  Lessons Learned after 30 Years
Pharmacognosy and Effects of Cannabinoids in the Vascular System
Goods and Bads of the Endocannabinoid System as a Therapeutic Target:  Lessons Learned after 30 Years
Biomedicines, Free Full-Text
Goods and Bads of the Endocannabinoid System as a Therapeutic Target:  Lessons Learned after 30 Years
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Goods and Bads of the Endocannabinoid System as a Therapeutic Target:  Lessons Learned after 30 Years
The Endocannabinoid System: Why Our Bodies Respond To Cannabis – Goldleaf
Goods and Bads of the Endocannabinoid System as a Therapeutic Target:  Lessons Learned after 30 Years
CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition - David Panikashvili, Raphael Mechoulam, Sara M Beni, Alexander Alexandrovich, Esther Shohami, 2005
Goods and Bads of the Endocannabinoid System as a Therapeutic Target:  Lessons Learned after 30 Years
The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses, Psychological Medicine
Goods and Bads of the Endocannabinoid System as a Therapeutic Target:  Lessons Learned after 30 Years
Full article: At the heart of microbial conversations: endocannabinoids and the microbiome in cardiometabolic risk
Goods and Bads of the Endocannabinoid System as a Therapeutic Target:  Lessons Learned after 30 Years
Frontiers Cannabis: a multifaceted plant with endless potentials
Goods and Bads of the Endocannabinoid System as a Therapeutic Target:  Lessons Learned after 30 Years
Cannabis, a complex plant: different compounds and different effects on individuals - Zerrin Atakan, 2012
Goods and Bads of the Endocannabinoid System as a Therapeutic Target:  Lessons Learned after 30 Years
The endocannabinoid system and its therapeutic exploitation
de por adulto (o preço varia de acordo com o tamanho do grupo)